首页|亚麻醉剂量艾司氯胺酮对剖宫产患者术后痛觉过敏及产后抑郁的影响

亚麻醉剂量艾司氯胺酮对剖宫产患者术后痛觉过敏及产后抑郁的影响

扫码查看
目的 探讨亚麻醉剂量艾司氯胺酮对全身麻醉剖宫产术后瑞芬太尼诱导的痛觉过敏的影响,并观察其对血清同型半胱氨酸(Hcy)水平及产后抑郁的影响。方法 选取择期行全身麻醉剖宫产的产妇50例,按照随机数字表法将其分为艾司氯胺酮组和对照组(每组25例)。两组分别在胎儿娩出后10 min给予艾司氯胺酮0。2 mg/kg、等量生理盐水缓慢注射。比较两组拔管时间、术后2 h内视觉模拟评分(VAS)得分及麻醉后监测治疗室(PACU)吗啡用量;比较两组术前1 d、术后1 d、术后4 d及术后1个月患者爱丁堡产后抑郁量表(EPDS)评分;检测两组术前1 d、术后1 d及术后4 d血清Hcy水平。结果 两组患者术后拔管时间差异无统计学意义(P>0。05);与对照组相比,艾司氯胺酮组首次出现VAS≥4分的时间延长,而从注射吗啡至VAS<4分所需时间缩短(P<0。05);艾司氯胺酮组PACU吗啡使用量低于对照组(P<0。05)。与对照组相比,艾司氯胺酮组术后15 min、30 min、45 min、1 h、90 min VAS评分均降低(P<0。05),而术后2 h两组患者VAS评分比较差异无统计学意义(P>0。05)。艾司氯胺酮组术后1 d和术后4 d EPDS评分低于对照组(P<0。05),而两组患者术后1个月EPDS评分差异无统计学意义(P>0。05)。艾司氯胺酮组术后1 d和术后4 d血清Hcy水平均低于对照组(P<0。05)。结论 全身麻醉剖宫产术中注射亚麻醉剂量艾司氯胺酮能有效缓解瑞芬太尼诱导的痛觉过敏,并预防产后抑郁的发生。
Effect of subanesthetic dose of esketamine on postoperative hyperalgesia and postpartum depression in patients undergoing caesarean section
Objective To investigate the effect of subanesthetic dose of esketamine on remifentanil-in-duced hyperalgesia after cesarean section under general anesthesia,and its effect on serum homocysteine(Hcy)level and postpartum depression.Methods A total of fifty patients undergoing cesarean section under general anesthesia were randomly divided into the esketamine group and the control group(25 cases in each group).The two groups were given esketamine 0.2 mg/kg and the same amount of normal saline by slow in-jection 10 min after fetal delivery.Then,the extubation time,visual analogue scale(VAS)score within two hours after operation,and consumption of morphine while in the post-anaesthesia care unit(PACU)were compared between the two groups.The Edinburgh Postnatal Depression Scale(EPDS)scores were compared at one day before surgery,one day,four days,and one month after surgery.Serum Hcy levels were measured at one day before surgery,one day and four days after surgery.Results There was no significant difference in extubation time between the two groups(P>0.05).Compared with the control group,it took a longer time for patients in the esketamine group to have a VAS score≥4 for the first time,but the time from morphine injection to a VAS score<4 was shortened(P<0.05).The amount of morphine used in the esketamine group was lower than that in the control group in PACU(P<0.05).Compared with the control group,the VAS scores of the esketamine group decreased at 15 min,30 min,45 min,one hour,and 90 min after surgery(P<0.05),while there was no statistical significance difference in VAS scores at two hours after surgery(P<0.05).EPDS scores in the esketamine group were lower than those in the control group at one day and four days after surgery(P>0.05),but there was no statistically significant between the two groups at one month after surgery(P>0.05).Serum Hcy level in the esketamine group was lower than that in the control group at one day and four days after surgery(P<0.05).Conclusion The subanesthetic dose of esketamine during caesarean section under general anesthesia can effectively relieve remifentanil-induced postoperative hy-peralgesia and prevent the occurrence of postpartum depression.

esketaminehyperalgesiapostpartum depressionhomocysteine

敖利、甘建辉、喻文立、白耀武、史金麟

展开 >

唐山市妇幼保健院麻醉科,河北唐山 063000

唐山市人民医院麻醉科,河北唐山 063000

天津市第一中心医院麻醉科,天津 300192

艾司氯胺酮 痛觉过敏 产后抑郁 同型半胱氨酸

河北省医学科学研究项目河北省自然科学基金项目

20221752H2020105018

2024

重庆医学
重庆市卫生信息中心,重庆市医学会

重庆医学

CSTPCD
影响因子:1.797
ISSN:1671-8348
年,卷(期):2024.53(5)
  • 34